Respifit S


Chronic obstructive pulmonary disease (COPD) 1) 2)

  • For COPD stage GOLD II-IV as an additive measure to established drug therapy and rehabilitation procedures.

Neuromuscular diseases 3)

  • Slow progressive course
  • Inspiratory vital capacity > 25% of the target value
  • paCO2 (partial pressure of carbon dioxide in blood) < 45 mmHg

Other medical conditions with respiratory muscle weakness, such as

  • Cystic fibrosis
  • Kyphoscoliosis or diaphragmatic dysfunction
  • Thoracic deformity
  • in the pre- and postoperative area during thoracic surgery
  • Chronic heart failure
  1. How Breathing Exercises Influence on Respiratory Muscles and Quality of Life among Patients with COPD? A Systematic Review and Meta-Analysis | Ruisheng Yun et al. Hindawi Canadian Respiratory Journal Volume 2021, Article ID 1904231

  2. Gültige Leitlinie Deutschland COPD

  3. Wanke et al | diverse Publikationen

Inquire now!